i2C Solutions, LLC — Department of Defense SBIR Phase I: A15-061
i2C Solutions, LLC — SBIR Phase I award from Department of Defense.
- Amount
- $99,994
- Agency
- Department of Defense · Army
- Program / Phase
- SBIR · Phase I
- Topic
- A15-061
- Solicitation
- 2015.1
- NAICS
- —
- Place of performance
- CO
- Period
- 2015-09-21 → 2016-04-20
Description
To address the need for improved treatment protocols that can ensure a higher rate of recovery from traumatic eye injury, i2C Solutions in collaboration with Oxygen Emulsion Company (OE Co), LLC, propose to develop a new topical therapy for ocular trauma that derives from a wound-healing technology originally funded by DARPA. The treatment involves application of a liquid peruorodecalin (PFD)/O2 emulsion to the eye. The anticipated therapeutic benefits include up-regulation in collagen I expression, a correlated increase in re-generation of damaged sclera, conjunctiva, corneal epithelium, and ocular adnexa dermal tissues, and acceleration of ocular wound healing.